Pharmaceutical group · Switzerland
Nycomed
A group of 12 companies with 12 medicines in 4 countries.
Group structure
12 companies in 7 countries
Loading…
Pharmaceutical group · Switzerland
A group of 12 companies with 12 medicines in 4 countries.
12 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| OMNARIS50mcg · Spray | Ciclesonide | United States | Marketed | 2007 |
| EUPHYLLIN AMP 0.24GM-10ML I.V | Theophylline | Saudi Arabia | Authorised | |
| EUPHYLLINE RTD.MITE C.TAB 175MG | Theophylline | Saudi Arabia | Authorised | |
| HOLOPON TAB 1MG | Butylscopolamine | Saudi Arabia | Authorised | |
| ANAGASTRA 20mg comprimidos gastrorresistentes22,6 mg · Comprimido gastrorresistente | Pantoprazole | Spain | Suspended | 2013 |
| HYPAQUE ORAL LIQUID - 50G/120ML50 g / 120 ml · Liquid | Diatrizoate | Canada | Cancelled | 1997 |
| HYPAQUE SODIUM 50% - LIQ IV50 % / % · Liquid | Diatrizoate | Canada | Cancelled | 1998 |
| PANTECTA 20 MG COMPRIMIDOS GASTRORRESISTENTES22,57 mg · Comprimido gastrorresistente | Pantoprazole | Spain | Withdrawn | 2013 |
| PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES45,10 mg · Comprimido gastrorresistente | Pantoprazole | Spain | Withdrawn | 2013 |
| PANTO-BYK20 mg · Tablet (Enteric-Coated) | Pantoprazole | Canada | Cancelled | |
| PANTO-BYK40 mg · Tablet (Enteric-Coated) | Pantoprazole | Canada | Cancelled | |
| TELEPAQUE - TABLET - 500MG500 mg · Tablet | Iopanoic acid | Canada | Cancelled | 1999 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 5 | 0 | 5 | CompaniesAll medicines |
| Spain | 3 | 0 | 3 | CompaniesAll medicines |
| Saudi Arabia | 3 | 3 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Nycomed’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.